- Projects & figures
- News & Events
- Managing your project
- About ERC
Jojo is an epidermal cell - as was his father and his grand-father before him. While the dream of his life is to become a neuron, he faces the hard and fundamental dogma of biology: once a skin cell, always a skin cell…
Prof. Gregoire Courtine believes paralysed patients will be able to walk again. This belief has represented the focus of years of work aimed at regenerating the functions of the spinal cord after injury. Thanks to his ERC funding in both 2010 and 2015, Prof. Courtine and his team have been able to develop so-called “personalised neuroprosthetics” that have led immobile rats, and more recently monkeys, to overcome their paralysis.
Ever since observing a map of a marine landslide as a young geology student, Dr Aaron Micallef was hooked on the beauty of the sea floor. Now, he works on understanding the forces that shape the Earth’s landscapes, both above ground and below the sea level. His MARCAN project studies the impacts of groundwater on canyon formation in Malta and New Zealand. This investigation may reveal where we will be getting our drinking water in the future.
For the first time ever, a team of scientists and clinicians led by the EU-funded researcher Mickael Tanter has managed to record the brain activity of a premature new-born baby during resting and during an epileptic seizure. Using a non-invasive ultrasound technology, this world premiere is a real game changer for researchers and the medical profession, offering a massive range of applications in neuroimaging and beyond. It is published today in Science Translational Medicine.
Pour la toute première fois, une équipe de scientifiques et des cliniciens dirigée par le chercheur Mickael Tanter, financé par l'UE, a réussi à enregistrer l'activité cérébrale d'un nouveau-né prématuré en phase de repos et lors d'une crise d'épilepsie. À l'aide d'une technologie d'échographie non invasive, cette première mondiale marque un véritable tournant dans le domaine de la recherche et la pratique médicale. Elle offre par ailleurs une vaste gamme d'applications en neuroimagerie et au-delà. L'étude est publiée aujourd'hui dans Science Translational Medicine.
First published on 09-10-2017Updated on 18/12/2018
Beyond the orbit of Neptune, there is a belt of objects composed of ice and rocks, among which four dwarf planets stand out: Pluto, Eris, Makemake and Haumea. Because of their small size, low reflectance, and far distance, these trans-neptunian objects are difficult to study and remain partly mysterious. A group of astronomers supported by the EU report on their unexpected finding on Haumea.
Our immune system recognizes and fights infections in a constantly changing environment, where new pathogenic threats emerge. At the crossroad between physics and biology, Prof. Aleksandra Walczak investigates the fascinating process that allows the immune system to be always ready to adapt and evolve to face new dangers.
Headscarves, mosques and halal shops — many EU citizens are Muslims, but visible signs of their faith are often viewed with distrust. What some Europeans see as a right to express their identity, others regard as a threat to societal core values. Insights from ERC-funded research into emblematic controversies may help to find a way forward.
The use and misuse of antibiotics has accelerated the emergence of drug-resistant bacterial strains, threatening our ability to treat common diseases. EU-funded research has shed new light on the mechanisms behind these microbial mutations, with implications for our understanding of diseases and resistance to treatment.
Maria Brandão de Vasconcelos, together with her colleague Filipa Matos Baptista, Henrique Veiga-Fernandes (ERC grantee), Diogo Fonseca Pereira and Sílvia Arroz Madeira, founded StemCell2MAX in 2015. The company is a biotechnology start-up, specialised in cell based therapies, including novel solutions to multiply the scarcely available blood stem cells, addressing an enormous demand for research and cancer treatment. StemCell2MAX technology is based on Prof. Veiga-Fernandes's ground-breaking discoveries in hematopoietic stem cell biology.
Originally published in March 2017 as part of the multimedia campaign "ERC - 10 years – 10 portraits."